Cargando…
Five-mer peptides prevent short-term spatial memory deficits in Aβ25-35-induced Alzheimer’s model mouse by suppressing Aβ25-35 aggregation and resolving its aggregate form
BACKGROUND: The development of drugs for Alzheimer’s disease (AD), which is related to the misfolding and aggregation of amyloid-β (Aβ), is high in demand due to the growing number of AD patients. In this study, we screened 22 kinds of 5-mer synthetic peptides derived from the Box A region of Tob1 p...
Autores principales: | Nakamura, Rina, Konishi, Motomi, Higashi, Youichirou, Saito, Motoaki, Akizawa, Toshifumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10114458/ https://www.ncbi.nlm.nih.gov/pubmed/37076912 http://dx.doi.org/10.1186/s13195-023-01229-2 |
Ejemplares similares
-
Non-aggregated Aβ25-35 Upregulates Primary Astrocyte Proliferation In Vitro
por: Ohki, Elise C., et al.
Publicado: (2017) -
De novo aggregation of Alzheimer’s Aβ25-35 peptides in a lipid bilayer
por: Smith, Amy K., et al.
Publicado: (2019) -
Structure–Activity Relationship of 5-mer Catalytides, GSGYR and RYGSG
por: Nakamura, Rina, et al.
Publicado: (2022) -
Catalytides derived from the Box A region in the ANA/BTG3 protein cleave amyloid-β fragment peptide
por: Hatakawa, Yusuke, et al.
Publicado: (2019) -
Nanostructural Differentiation and Toxicity of Amyloid-β25-35 Aggregates Ensue from Distinct Secondary Conformation
por: Song, Yongxiu, et al.
Publicado: (2018)